Benrimoh, David
Azeez, Azeezat
Batail, Jean-Marie
Xiao, Xiaoqian
Buchanan, Derrick
Bandeira, Igor D.
Geoly, Andrew
Keynan, Yaakov
Kratter, Ian H.
Williams, Nolan R.
Article History
Received: 3 April 2024
Accepted: 21 October 2024
First Online: 28 October 2024
Competing interests
: N.R.W. is a named inventor on Stanford-owned intellectual property relating to accelerated TMS pulse pattern sequences and neuroimaging-based TMS targeting; he has served on scientific advisory boards for Otsuka, NeuraWell, Magnus Medical, and Nooma as a paid advisor; and he has equity/stock options in Magnus Medical, NeuraWell, and Nooma. D.B. is a founder, shareholder, and officer of Aifred Health, a digital mental health company whose work is unrelated to this article. All other investigators declare no conflicts of interest. D.B. is a founder and shareholder of CanadaNeuro, a mental health company whose work is unrelated to this publication and which did not support this work.